None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects in age group 18 - 55 years (both the ages inclusive). 2. Healthy male & female subjects. 3. Subjects with Fitzpatrick skin type III to V. 4. Subjects willing to give a written informed consent. 5. Subjects willing to maintain the patch test in position for 24 hours. 6. Subject having not participated in a similar investigation in the past one month. 7. Subjects willing to come for regular follow up visits. 8. Subjects ready to follow instructions during the study period. Test period: 9 days for all subjects including screening day.
Exclusion criteria
Exclusion criteria: 1. Infection, allergy on the tested area. 2. Skin allergy, antecedents or atopic subjects. 3. Athletes and subjects with history of excessive sweating. 4. Cutaneous disease which may influence the study result. 5. Subjects on oral corticosteroid . 6. Subjects participating in any other cosmetic or therapeutic study. 7. Any history of underlying uncontrolled medical illness including diabetes, liver disease or history of alcoholism, HIV or any other serious medical illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The objective of this study is to evaluate the dermatological safety of the given investigational product/s on skin of healthy human volunteers by dermatological visual assessmentTimepoint: 24 hrs | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse event monitoringTimepoint: 0 hr to 24 hrs | — |
Countries
India
Contacts
Entice Supplements Pvt Ltd